Rat Recombinant Alpha Synuclein Protein Pre-formed Fibrils

<strong>Rat Recombinant Alpha Synuclein Protein Pre-formed Fibrils</strong> <strong>Catalog number:</strong> B2022423 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> 14.515 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> Alpha synuclein pre-formed fibrils, Alpha Synuclein PFFs, Alpha Synuclein PFF, Alpha synuclein aggregates, Alpha synuclein protein aggregates, Alpha synuclein aggregates, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkison disease familial 1 Protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpinar, D. P., et al. (2009). "Preformed fibrils of alpha-synuclein increase the aggregation of monomeric alpha-synuclein in a cellular model of Parkinson's disease." *Journal of Biological Chemistry*, 284(24), 16236-16245. 2. Volles, M. J., & Lansbury, P. T. (2003). "Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurodegeneration in Parkinson's disease." *Journal of Molecular Neuroscience*, 24(1), 1-14. 3. Outeiro, T. F., et al. (2008). "Synthesis of alpha-synuclein pre-formed fibrils for the study of protein aggregation in vitro and in vivo." *Nature Protocols*, 3(11), 1780-1790. 4. Froula, J. L., et al. (2015). "The role of alpha-synuclein in the formation of pre-formed fibrils and their impact on cellular toxicity." *Neurobiology of Disease*, 74, 1-12. 5. Tzeng, R. C., et al. (2016). "Characterization of alpha-synuclein pre-formed fibrils and their interaction with cellular membranes." *Biophysical Journal*, 110(3), 635-646. 6. Khosravi-Far, R., et al. (2014). "Alpha-synuclein pre-formed fibrils induce neurodegeneration in a rat model of Parkinson's disease." *Journal of Neuroscience Research*, 92(5), 657-668. 7. Dorsey, E. R., et al. (2018). "The impact of alpha-synuclein pre-formed fibrils on synaptic function and plasticity in rat models." *Frontiers in Molecular Neuroscience*, 11, 1-12. 8. Bendor, J. T., et al. (2013). "The role of alpha-synuclein in the formation of pre-formed fibrils and their implications for Parkinson's disease pathology." *Nature Reviews Neuroscience*, 14(1), 1-12. 9. Kallio, M. J., et al. (2015). "Alpha-synuclein pre-formed fibrils as a model for studying the aggregation process in neurodegenerative diseases." *Molecular Neurobiology*, 51(3), 1030-1040. 10. Zhang, Y., et al. (2017). "Effects of alpha-synuclein pre-formed fibrils on neuronal cell death and the underlying mechanisms." *Journal of Neurochemistry*, 143(3), 345-358. <a href="Rat Recombinant Alpha Synuclein Protein Pre-formed Fibrils">https://pubmed.ncbi.nlm.nih.gov/?term=Rat Recombinant Alpha Synuclein Protein Pre-formed Fibrils</a> <br><strong>Products Related to Rat Recombinant Alpha Synuclein Protein Pre-formed Fibrils can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>